Castleview Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Buy |
4,227
+513
| +14% | +$56.9K | 0.3% | 83 |
|
|
2025
Q1 | $416K | Sell |
3,714
-460
| -11% | -$51.5K | 0.28% | 94 |
|
|
2024
Q4 | $384K | Buy |
4,174
+674
| +19% | +$61.9K | 0.21% | 119 |
|
|
2024
Q3 | $293K | Buy |
3,500
+143
| +4% | +$12K | 0.17% | 141 |
|
|
2024
Q2 | $230K | Buy |
3,357
+899
| +37% | +$61.7K | 0.13% | 154 |
|
|
2024
Q1 | $180K | Buy |
2,458
+819
| +50% | +$60K | 0.1% | 189 |
|
|
2023
Q4 | $133K | Sell |
1,639
-3
| -0.2% | -$243 | 0.09% | 171 |
|
|
2023
Q3 | $123K | Buy |
1,642
+19
| +1% | +$1.42K | 0.11% | 153 |
|
|
2023
Q2 | $125K | Sell |
1,623
-1,176
| -42% | -$90.6K | 0.11% | 159 |
|
|
2023
Q1 | $232K | Buy |
2,799
+113
| +4% | +$9.38K | 0.21% | 113 |
|
|
2022
Q4 | $231K | Sell |
2,686
-66
| -2% | -$5.67K | 0.22% | 104 |
|
|
2022
Q3 | $170K | Buy |
2,752
+1,052
| +62% | +$65K | 0.16% | 137 |
|
|
2022
Q2 | $24.1K | Sell |
1,700
-1,100
| -39% | -$15.6K | 0.02% | 372 |
|
|
2022
Q1 | $166K | Sell |
2,800
-219,386
| -99% | -$13M | 0.1% | 187 |
|
|
2021
Q4 | $3.06K | Buy |
+222,186
| New | +$3.06K | 0.02% | 226 |
|
|
2021
Q2 | $103K | Buy |
+1,496
| New | +$103K | 0.05% | 281 |
|